Equities

Airsculpt Technologies Inc

AIRS:NMQ

Airsculpt Technologies Inc

Actions
Health CareHealth Care Providers
  • Price (USD)7.41
  • Today's Change-0.57 / -7.14%
  • Shares traded253.59k
  • 1 Year change+47.61%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments109.6225
Total Receivables, Net1.942.83--
Total Inventory------
Prepaid expenses3.764.234.09
Other current assets, total------
Total current assets161729
Property, plant & equipment, net544832
Goodwill, net828282
Intangibles, net465156
Long term investments------
Note receivable - long term------
Other long term assets5.663.281.74
Total assets204201201
LIABILITIES
Accounts payable3.923.842.67
Accrued expenses131410
Notes payable/short-term debt000
Current portion long-term debt/capital leases2.132.130.85
Other current liabilities, total1.462.362.81
Total current liabilities202216
Total long term debt708182
Total debt728483
Deferred income tax6.835.494.35
Minority interest------
Other liabilities, total232115
Total liabilities120130117
SHAREHOLDERS EQUITY
Common stock0.060.060.06
Additional paid-in capital1048684
Retained earnings (accumulated deficit)(20)(15)(0.39)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(0.41)(0.08)--
Total equity847184
Total liabilities & shareholders' equity204201201
Total common shares outstanding575656
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.